Left bundle branch block-induced cardiomyopathy: a diagnostic proposal for a poorly explored pathological entity
Giuseppe D Sanna1, Marco Merlo2, Eleonora Moccia1
1Clinical and Interventional Cardiology, Sassari University Hospital, Sassari, Italy.
International Journal of Cardiology
|June 13, 2019
Summary
Left bundle branch block (LBBB)-induced cardiomyopathy is often diagnosed late. Early detection through clinical, ECG, and imaging signs may improve prognosis and allow timely cardiac resynchronization therapy (CRT).
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Left bundle branch block (LBBB)-induced cardiomyopathy is increasingly recognized but not formally classified.
- Current diagnosis is often post-hoc, based on response to cardiac resynchronization therapy (CRT).
Purpose of the Study:
- To describe the relationship between LBBB and left ventricular dysfunction.
- To provide a multiparametric approach for early detection of LBBB-induced cardiomyopathy.
Main Methods:
- Review of the complex relationship between LBBB and non-ischaemic left ventricular dysfunction.
- Proposal of a multiparametric approach using clinical, electrocardiographic, and imaging "red flags".
Main Results:
- Early detection of LBBB-induced cardiomyopathy could have significant clinical and therapeutic implications.
- Patients may benefit from early CRT, potentially leading to a better prognosis than in primary muscle cell disorders.
Conclusions:
- Early identification of LBBB-induced cardiomyopathy is crucial.
- A multiparametric approach can aid in the early detection of this condition, differentiating it from primary dilated cardiomyopathy.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
502
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
502
Cardiomyopathy III: Hypertrophic Cardiomyopathy
440
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
440
Cardiomyopathy IV: Restrictive Cardiomyopathy
490
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
490
Cardiomyopathy V: Interprofessional Care
365
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
365
Cardiomyopathy I: Introduction and Classification
535
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
535
Cardiomyopathy VI: Nursing Management
326
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
326


